BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9518221)

  • 21. High-intensity basal ganglia lesions on T1-weighted MR images in neurofibromatosis.
    Mirowitz SA; Sartor K; Gado M
    AJR Am J Roentgenol; 1990 Feb; 154(2):369-73. PubMed ID: 2105032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-intensity basal ganglia lesions on T1-weighted MR images in neurofibromatosis.
    Mirowitz SA; Sartor K; Gado M
    AJNR Am J Neuroradiol; 1989; 10(6):1159-63. PubMed ID: 2512777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central nervous system imaging in reevaluation of patients with neurofibromatosis type 1.
    Balestri P; Calistri L; Vivarelli R; Bartalini G; Mancini L; Berardi A; Fois A
    Childs Nerv Syst; 1993 Dec; 9(8):448-51. PubMed ID: 8124670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brainstem lesions in neurofibromatosis type 1.
    Ullrich NJ; Raja AI; Irons MB; Kieran MW; Goumnerova L
    Neurosurgery; 2007 Oct; 61(4):762-6; discussion 766-7. PubMed ID: 17986937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain.
    DiPaolo DP; Zimmerman RA; Rorke LB; Zackai EH; Bilaniuk LT; Yachnis AT
    Radiology; 1995 Jun; 195(3):721-4. PubMed ID: 7754001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of "unidentified bright objects" on MRI for diagnosis of neurofibromatosis 1 in children.
    DeBella K; Poskitt K; Szudek J; Friedman JM
    Neurology; 2000 Apr; 54(8):1646-51. PubMed ID: 10762507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Brain stem tumors associated with neurofibromatosis type 1. Presentation of 20 infantile patients].
    Pascual Castroviejo I; Pascual Pascual S; Velázquez Fragua R; Viaño J; Garcia Segura JM
    Neurologia; 2007 Dec; 22(10):846-52. PubMed ID: 17671854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is magnetic resonance spectroscopy capable of detecting metabolic abnormalities in neurofibromatosis type 1 that are not revealed in brain parenchyma of normal appearance?
    Rodrigues AC; Ferraz-Filho JR; Torres US; da Rocha AJ; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino ÉC
    Pediatr Neurol; 2015 Mar; 52(3):314-9. PubMed ID: 25585912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MR imaging of optic pathways in patients with neurofibromatosis.
    Brown EW; Riccardi VM; Mawad M; Handel S; Goldman A; Bryan RN
    AJNR Am J Neuroradiol; 1987; 8(6):1031-6. PubMed ID: 3120529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cervical neurofibromas in children with NF-1.
    Chung CJ; Armfield KB; Mukherji SK; Fordham LA; Krause WL
    Pediatr Radiol; 1999 May; 29(5):353-6. PubMed ID: 10382213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 in children < or = 6 years and clinically suspected of having NF1. Neurofibromatosis team of Sophia Children's Hospital.
    Cnossen MH; Moons KG; Garssen MP; Pasmans NM; de Goede-Bolder A; Niermeijer MF; Grobbee DE
    J Med Genet; 1998 Aug; 35(8):624-7. PubMed ID: 9719365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surveillance magnetic resonance imaging for isolated optic pathway gliomas: is gadolinium necessary?
    Maloney E; Stanescu AL; Perez FA; Iyer RS; Otto RK; Leary S; Steuten L; Phipps AI; Shaw DWW
    Pediatr Radiol; 2018 Sep; 48(10):1472-1484. PubMed ID: 29789890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-neoplastic brain abnormalities on MRI in children and adolescents with neurofibromatosis type 1.
    Raininko R; Thelin L; Eeg-Olofsson O
    Neuropediatrics; 2001 Oct; 32(5):225-30. PubMed ID: 11748492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Early diagnostic significance and dynamic pattern of DWI compared with conventional MRI in newborns with neonatal cerebral infarction].
    Fu JH; Mao J; Xue XD; You K
    Zhonghua Er Ke Za Zhi; 2007 May; 45(5):360-4. PubMed ID: 17697623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CT detection of basal ganglion lesions in neurofibromatosis type 1: correlation with MRI.
    Menor F; Marti-Bonmatí L
    Neuroradiology; 1992; 34(4):305-7. PubMed ID: 1528439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epileptic seizures in neurofibromatosis type 1 are related to intracranial tumors but not to neurofibromatosis bright objects.
    Hsieh HY; Fung HC; Wang CJ; Chin SC; Wu T
    Seizure; 2011 Oct; 20(8):606-11. PubMed ID: 21621428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain stem involvement in children with neurofibromatosis type 1: role of magnetic resonance imaging and spectroscopy in the distinction from diffuse pontine glioma.
    Broniscer A; Gajjar A; Bhargava R; Langston JW; Heideman R; Jones D; Kun LE; Taylor J
    Neurosurgery; 1997 Feb; 40(2):331-7; discussion 337-8. PubMed ID: 9007866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased brain apparent diffusion coefficient in children with neurofibromatosis type 1.
    Eastwood JD; Fiorella DJ; MacFall JF; Delong DM; Provenzale JM; Greenwood RS
    Radiology; 2001 May; 219(2):354-8. PubMed ID: 11323456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Globus pallidus MR signal abnormalities in children with chronic liver disease and/or porto-systemic shunting.
    Hanquinet S; Morice C; Courvoisier DS; Cousin V; Anooshiravani M; Merlini L; McLin VA
    Eur Radiol; 2017 Oct; 27(10):4064-4071. PubMed ID: 28386718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic resonance imaging lesion analysis in neurofibromatosis type 1.
    DiMario FJ; Ramsby G
    Arch Neurol; 1998 Apr; 55(4):500-5. PubMed ID: 9561977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.